母亲妊娠期高血压疾病与子代从出生到青年期死亡率的关联:全国人群队列研究
该研究基于丹麦全国健康登记数据,纳入1978—2018年出生的2437718名活产儿,随访至死亡、移民或2018年12月31日。母亲有妊娠期高血压疾病(HDP)者102095例,其中子痫前期67683例、子痫679例、高血压33733例。中位随访19.4年,暴露组与非暴露组全因死亡累积发生率差为0.37%(95%CI 0.11%至0.64%),人群归因分数1.09%(95%CI 0.77%至1.41%)。母亲HDP与子代全因死亡风险升高26%相关(HR 1.26,95%CI 1.18至1.34),子痫前期、子痫、高血压的HR分别为1.29(1.20至1.38)、2.88(1.79至4.63)、1.12(0.98至1.28)。多种死因风险亦升高,早发型重度子痫前期及HDP合并糖尿病或低教育水平者风险更明显。
要点
- 母亲HDP与子代全因死亡风险升高26%相关(HR 1.26,95%CI 1.18至1.34),子痫(HR 2.88,95%CI 1.79至4.63)和子痫前期(HR 1.29,95%CI 1.20至1.38)风险更高。
- 母亲单纯高血压与子代全因死亡风险无显著关联(HR 1.12,95%CI 0.98至1.28,95%CI跨1)。
- 围产期疾病(HR 2.04,95%CI 1.81至2.30)、心血管疾病(HR 1.52,95%CI 1.08至2.13)、消化系统疾病(HR 2.09,95%CI 1.27至3.43)、内分泌营养代谢疾病(HR 1.56,95%CI 1.08至2.27)死亡风险升高。
- 早发型重度子痫前期子代全因死亡风险最高(HR 6.06,95%CI 5.35至6.86),HDP合并糖尿病(HR 1.57,95%CI 1.16至2.14)或低教育水平(HR 1.49,95%CI 1.34至1.66)风险亦增加。
- 暴露组与非暴露组全因死亡累积发生率差0.37%(95%CI 0.11%至0.64%),人群归因分数1.09%(95%CI 0.77%至1.41%)。
适用人群与场景
- 纳入1978—2018年在丹麦活产的所有2437718名个体,随访自出生至死亡、移民或2018年12月31日。
- 母亲有妊娠期高血压疾病者102095例:子痫前期67683例、子痫679例、高血压33733例;其余母亲无HDP。
研究设计与关键结果
- 全国人群队列研究,纳入2437718名活产儿,母亲HDP 102095例,中位随访19.4年(四分位距9.7至28.7年)。
- 全因死亡:子痫前期母亲子代781例死亡(58.94/10万人年),子痫母亲子代17例(133.73/10万人年),高血压母亲子代223例(44.38/10万人年),无HDP母亲子代19119例(41.99/10万人年)。
- 母亲HDP与子代全因死亡风险升高26%相关(HR 1.26,95%CI 1.18至1.34);子痫前期HR 1.29(1.20至1.38),子痫HR 2.88(1.79至4.63),高血压HR 1.12(0.98至1.28,未达统计学显著)。
- 死因别死亡风险:围产期疾病HR 2.04(1.81至2.30),心血管疾病HR 1.52(1.08至2.13),消化系统疾病HR 2.09(1.27至3.43),内分泌营养代谢疾病HR 1.56(1.08至2.27)。
- 早发型重度子痫前期子代全因死亡HR 6.06(5.35至6.86);HDP合并糖尿病史HR 1.57(1.16至2.14);HDP合并低教育水平HR 1.49(1.34至1.66)。
- 暴露组与非暴露组全因死亡累积发生率差0.37%(95%CI 0.11%至0.64%),人群归因分数1.09%(95%CI 0.77%至1.41%)。
证据类型、等级与局限
- 证据类型:全国人群基于登记的队列研究,采用Cox回归校正多个潜在混杂因素。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,母亲HDP尤其子痫和重度子痫前期与子代从出生至青年期全因死亡及多种死因别死亡风险升高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To examine the association of maternal hypertensive disorder of pregnancy (HDP) with overall and cause specific mortality in offspring from birth to young adulthood.
DESIGN: Nationwide population based cohort study.
SETTING: Danish national health registers.
PARTICIPANTS: All 2 437 718 individuals live born in Denmark, 1978-2018, with follow-up from date of birth until date of death, emigration, or 31 December 2018, whichever came first.
MAIN OUTCOME MEASURES: The primary outcome was all cause mortality. Secondary outcomes were 13 specific causes of death in offspring from birth to young adulthood (age 41 years). Cox regression was used to assess the association, taking into consideration several potential confounders. The role of timing of onset and severity of pre-eclampsia, maternal history of diabetes, and maternal education were also studied.
RESULTS: 102 095 mothers had HDP: 67 683 with pre-eclampsia, 679 with eclampsia, and 33 733 with hypertension. During follow-up to 41 years (median 19.4 (interquartile range 9.7-28.7) years), deaths occurred in 781 (58.94 per 100 000 person years) offspring born to mothers with pre-eclampsia, 17 (133.73 per 100 000 person years) born to mothers with eclampsia, 223 (44.38 per 100 000 person years) born to mothers with hypertension, and 19 119 (41.99 per 100 000 person years) born to mothers with no HDP. The difference in cumulative incidence in overall mortality between cohorts exposed and unexposed to maternal HDP was 0.37% (95% confidence interval 0.11% to 0.64%), and the population attributable fraction for maternal HDP was estimated as 1.09% (95% confidence interval 0.77% to 1.41%). Maternal HDP was associated with a 26% (hazard ratio 1.26, 95% confidence interval 1.18 to 1.34) higher risk of all cause mortality in offspring. The corresponding estimates for maternal pre-eclampsia, eclampsia, and hypertension were 1.29 (1.20 to 1.38), 2.88 (1.79 to 4.63), and 1.12 (0.98 to 1.28). Increased risks were also observed for several cause specific mortalities, such as deaths from conditions originating in the perinatal period (2.04, 1.81 to 2.30), cardiovascular diseases (1.52, 1.08 to 2.13), digestive system diseases (2.09, 1.27 to 3.43), and endocrine, nutritional, and metabolic diseases (1.56, 1.08 to 2.27). The increased risks were more pronounced among offspring of mothers with early onset and severe pre-eclampsia (6.06, 5.35 to 6.86) or with both HDP and diabetes history (1.57, 1.16 to 2.14) or HDP and low education level (1.49, 1.34 to 1.66).
CONCLUSION: Maternal HDP, particularly eclampsia and severe pre-eclampsia, is associated with increased risks of overall mortality and various cause specific mortalities in offspring from birth to young adulthood.
参考来源
- Huang C, Wei K, Lee PMY, et al. Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study. BMJ. 2022. PMID: 36261141. doi:10.1136/bmj-2022-072157
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。